Background-Left ventricular (LV) global longitudinal strain (GLS) is a measure of the active shortening of the LV in the longitudinal direction, which can be assessed with speckle-tracking echocardiography. The aims of this evaluation were to validate the prognostic value of GLS as a new index of LV systolic function in a large cohort of patients with chronic ischemic cardiomyopathy and to determine the incremental value of GLS to predict long-term outcome over other strong and well-established prognostic factors. Methods and Results-A total of 1060 patients underwent baseline clinical evaluation and transthoracic echocardiography.
Clinical Perspective on p 391
Recently, new parameters derived from 2-dimensional (2D) speckle-tracking echocardiography permit the assessment of active myocardial deformation in multiple directions (radial, circumferential, and longitudinal). 8 -10 Particularly, the measurement of LV global longitudinal strain (GLS), which is a measure of the active shortening of the LV in the longitudinal direction, is more reproducible than LVEF and WMSI and does not rely on geometric assumptions. [11] [12] [13] Thus far, preliminary data suggest that LV GLS may be superior to LVEF and WMSI for the prediction of long-term outcome in different populations. 14 However, whether LV GLS is related to long-term outcome in patients with chronic ischemic heart disease is not established yet. Accordingly, the aims of this evaluation were to validate the prognostic value of LV GLS as new index of LV systolic function in a large cohort of patients with chronic ischemic cardiomyopathy and to determine the incremental value of LV GLS to predict long-term outcome over other strong and well-established clinical, ECG, and echocardiographic prognostic factors. heart disease. Patients with known coronary artery disease and prior myocardial infarction (Ͼ90 days before the index echocardiography) who underwent echocardiography between 1999 and 2009 were included in the present evaluation. This patient cohort formed part of ongoing institutional registries. 15, 16 Clinical and echocardiographic data were prospectively entered into the departmental Cardiology Information System (EPD-Vision, Leiden University Medical Center) and the echocardiography database, respectively. All patients received optimal medical treatment and coronary revascularization according to the current guidelines. 17, 18 In the present evaluation, atrial fibrillation, recent myocardial infarction (Ͻ90 days), and poor acoustic window resulting in inadequate speckle-tracking analysis were exclusion criteria.
All patients underwent an extensive baseline clinical history and physical examination, 12-lead ECG, and transthoracic echocardiography. Baseline clinical variables included New York Heart Association (NYHA) functional class, cardiovascular risk factors, medical treatment, and glomerular filtration rates (GFR) calculated by the Modification of Diet in Renal Disease formula as recommended by the National Kidney Foundation, Kidney Disease Outcomes Quality Initiative Guidelines. 19 Baseline echocardiographic variables included LV volumes, LVEF, WMSI, and LV GLS. All patients were prospectively followed up for the occurrence of death for any cause. From the various clinical, ECG, and echocardiographic variables recorded, independent determinants of all-cause mortality were identified.
Echocardiography
Transthoracic echocardiography was performed with the patients at rest in the left lateral decubitus position with commercially available ultrasound equipment (M4S probe, Vivid 7, GE-Vingmed, Horten, Norway). All images were digitally stored on hard disks for offline analysis (EchoPAC version 108.1.5, GE-Vingmed, Horten, Norway).
LV end-diastolic volume (EDV) and end-systolic volume (ESV) were calculated using the Simpson biplane method of discs. LVEF was calculated and expressed as a percentage. To calculate the WMSI, the LV was divided into 16 segments. A semiquantitative scoring system (1, normal; 2, hypokinesia; 3, akinesia; and 4, dyskinesia) was used to analyze each study. Global WMSI was calculated by the standard formula: sum of the segment scores divided by the number of segments scored. 20
Speckle-Tracking Longitudinal Strain Analysis
In the present evaluation, global systolic LV myocardial function was determined with 2D speckle-tracking strain analysis. 12, 21, 22 The speckle-tracking software tracks the frame-to-frame movement of natural myocardial acoustic markers, or speckles, on standard grayscale images. Speckle-tracking analysis is angle-independent and allows accurate evaluation of myocardial deformation in all the LV segments. 8, 10 The change in length/initial length of the speckle pattern over the cardiac cycle is used to calculate longitudinal strain, with myocardial lengthening or stretching represented as positive strain, and myocardial shortening as negative strain.
To quantify LV GLS, 2D speckle-tracking analyses were performed on standard routine gray-scale images of the apical 2-chamber, 4-chamber, and long-axis views. During analysis, the endocardial border was manually traced at an end-systolic frame and the software traced automatically a region of interest that includes the entire myocardium. The width of the region of interest could be manually adjusted to ensure proper tracking of the myocardial wall. The software then automatically tracked natural myocardial acoustic markers and accepted segments of good tracking quality and rejected poorly tracked segments while allowing the observer to manually override its decisions based on visual assessments of tracking quality. Results of the LV longitudinal strain analysis were automatically displayed as a 17-segment polar map model with 17 segmental/regional strain values and a mean global strain value for the entire LV ( Figure 1 ). 12, 22, 23 Previously reported intraobserver and interobserver variabilities for LV GLS analysis expressed as mean absolute difference Ϯ1 SD were 1.2Ϯ0.5% and 0.9Ϯ1.0%, respectively. 22
Follow-Up and End Points
Patients were followed up at 6-to 12-month intervals according to protocol. 15, 16 Data on the occurrence of adverse events at follow-up were collected by reviewing medical records, retrieval of survival status through the municipal civil registries, and telephone interviews. In the present evaluation, all-cause mortality and heart failure hospitalizations were recorded as event. Patients without data on the last 6 months were considered as lost to clinical follow-up. Data of these patients were included up to the last date of follow-up. From the various clinical, ECG, and echocardiographic variables recorded, independent determinants of all-cause mortality were identified. 
Statistical Analysis
For uniformity reasons, continuous variables were presented as median and interquartile range (IQR). Categorical variables were presented as frequencies and percentages and were compared using 2 test with Yates correction. The Mann-Whitney U test was used to compare unpaired continuous variables. Cumulative event rates from the time of inclusion were calculated using the Kaplan-Meier method for each independent predictor of all-cause mortality. The log-rank tests for time-to-event data with respect to the primary outcome were used for statistical comparison between 2 patient groups.
Multivariate Cox proportional hazards models were constructed to identify independent clinical, ECG, and echocardiographic determinants of all-cause mortality and combined end point. Univariate variables with a probability value Ͻ0.10 were entered as covariates, using the stepwise backward likelihood ratio selection method. In all the analyses, the Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for those independent variables. To avoid multicolinearity between the univariate predictors, a correlation coefficient of Ͻ0.7 (corresponding to a tolerance of Ͼ0.5) was set. The correlation coefficients between LV GLS and LVEF and WMSI were 0.87 and 0.85, respectively (both PϽ0.001), whereas the correlation coefficient between LVEF and WMSI was 0.88 (PϽ0.001). Accordingly, the independent predictive value of echocardiographic variables such as WMSI, LVEF, and GLS was evaluated in different multivariate models. Independent clinical and ECG predictors of all-cause mortality and the combined end point with a probability value Ͻ0.05 in the multivariate model using backward selection were included in these final models. Finally, the incremental value of LV GLS to predict long-term outcome over WMSI and LVEF was assessed by calculating the increment in the Harrell C concordance statistic. 24 A 2-sided probability value of Ͻ0.05 was considered significant. All statistical analyses were performed using SPSS for Windows (SPSS Inc, Chicago, IL), version 15, and STATA software (version 10.1, StataCorp, College Station, TX). Table 1 . Hypertension, dyslipidemia, and diabetes were present in 459 (43%), 440 (41%), and 298 (28%) patients, respectively. Most patients were treated with antiplatelets and/or oral anticoagulants (92%), ␤-blockers (69%), and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (84%). In addition, 606 (57%) patients received an implantable cardioverter-defibrillator device. Furthermore, 32% underwent prior coronary-aorto bypass grafting, whereas 25% underwent percutaneous coronary intervention. The remaining 43% of patients received optimal medical treatment. Table 2 summarizes the echocardiographic characteristics of the patient population. The median LVEDV, LVESV, and LVEF were 140 mL (IQR, 91-199 mL), 87 mL (IQR, 39 -150 mL), and 34% (IQR, 25% to 58%), respectively. The median WMSI was 1.5 (IQR, 1.0 -2.0), and the median LV GLS was -11.5% (IQR, Ϫ17.0% to Ϫ7.6%).
Survivors Versus Nonsurvivors
The median follow-up duration for the entire patient population was 31.0 months (IQR, 15.5, 52.7 months). A total of 270 (25%) patients died during the study duration, and the median time to death was 25.9 months (IQR, 13.0, 44.5 months). Differences in baseline clinical, ECG, and echocardiographic variables between patients who died and patients who survived are outlined in Tables 1 and 2 . Patients who died were more likely to be older (PϽ0.001) and diabetic (PϽ0.001) and to be in NYHA functional class III-IV (PϽ0.001). Interestingly, patients who died had lower hemoglobin (Pϭ0.004) and GFR (PϽ0.001). In addition, they had a higher heart rate (Pϭ0.005) and wider QRS complex (Pϭ0.001). Regarding echocardiographic parameters, patients who died had larger LVEDV (Pϭ0.012) and LVESV (Pϭ0.005) and lower LVEF (Pϭ0.004). Finally, patients who died had higher WMSI (Pϭ0.001) and a greater impairment of LV GLS (PϽ0.001).
Follow-Up
Kaplan-Meier curves for LV GLS of all-cause mortality in ischemic cardiomyopathy patients are reported in Figure 2A . Particularly, when the patient population was dichotomized based on the median LV GLS (Ϫ11.5%), a cumulative 4%, 10%, and 17% of patients with an LV GLS ՅϪ11.5% (less impaired LV shortening) died by 1, 2, and 3 years follow-up, respectively. In contrast, a respective 7%, 17%, and 27% of patients with an LV GLS ϾϪ11.5% (more impaired LV shortening) died during the same time period (log-rank 2 ϭ13.86, PϽ0.001; Figure 2A ). In addition, the combined end point (heart failure hospitalization and all-cause mortality) was reached by 309 patients during the follow-up. Kaplan-Meier estimates of the time to the combined end point for patients with an LV GLS ՅϪ11.5% and patients with an LV GLS ϾϪ11.5% are indicated in Figure 2B . After 3 years of follow-up, the cumulative free survival rates of combined end point in the group of patients with an LV GLS ՅϪ11.5% were 6%, 13%, and 20% at 1, 2, and 3 years of follow-up, respectively. In contrast, the group of patients with an LV GLS ϾϪ11.5% showed cumulative free survival rates of combined end point of 10%, 20%, and 29% at 1, 2, and 3 years of follow-up, respectively (log-rank 2 ϭ14.16, PϽ0.001; Figure 2B ).
Predictors of All-Cause Mortality and Combined End Point
To identify predictors of all-cause mortality, univariate Cox analyses were performed. First, among various clinical and ECG variables, the independent determinants were identified (Table 3) . Age, diabetes mellitus, hemoglobin, and renal function (measured with GFR) were independent determinants of all-cause mortality. Next, several echocardiographic variables of LV function were introduced in different multivariate models to evaluate their prognostic value (Table 4 ). WMSI (HR, 1.43; 95% CI, 1.14 -1.79; Pϭ0.002), LVEF (HR, 1.04; 95% CI, 1.00 -1.08; Pϭ0.026), and LV GLS (HR, 1.69; 95% CI, 1.33-2.15; PϽ0.001) were significantly associated with all-cause mortality. However, the model including LV GLS had the best relative fit, and LV GLS provided the highest Harrell C concordance statistics ( Table 5 ).
In addition, the clinical and ECG variables that were independently associated with the combined end point (heart failure hospitalization and all-cause mortality) were age, diabetes mellitus, and renal function. The predictive value of WMSI, LVEF, and LV GLS was evaluated in different multivariate Cox regression analyses to avoid multicolinearity. WMSI (HR, 1.44; 95% CI, 1.16 -1.78; Pϭ0.001), LVEF (HR, 1.04; 95% CI, 1.00 -1.08; Pϭ0.009), and LV GLS (HR, 1.64; 95% CI, 1.32-2.04; PϽ0.001) were independent predictors of the combined end point (Table 4 ). In addition, the model including LV GLS had the highest Harrell C statistic ( Table 5 ).
Discussion
The main findings of the present study were as follows: (1) LV GLS was significantly related to long-term outcome; (2) the predictive model including LV GLS provided the best relative fit, and, finally, (3) LV GLS was independently related to all-cause mortality and combined end point and had prognostic incremental value over other well-established clinical and ECG predictors.
GLS Versus LVEF and WMSI
As previously described, LVEF and WMSI are important echocardiographic prognosticators, especially in patients with coronary artery disease. [3] [4] [5] [6] [7] However, the assessment of LVEF and WMSI has several limitations. The measurement of LVEF with 2D echocardiography is based on geometric assumptions used to calculate LV volumes. Although the biplane Simpson method is the most accurate 2D measurement to calculate LVEF, the presence of wall motion abnormalities or distorted LV geometry may reduce the accuracy of this method to estimate LV systolic function and increase the intraobserver and interobserver variability. Moreover, the assessment of WMSI is based on visual assessment and requires high expertise.
At present, speckle-tracking echocardiography is emerging as a novel technique to allow the assessment of LV mechanics through the quantification of active myocardial deformation. 8 -10 Cumulative data show that unlike LVEF and WMSI, the assessment of LV mechanics with 2D speckle-tracking strain imaging is feasible and reproducible, does not rely on geometric assumptions, and is independent of LV geometry. 8 -10 In particular, the assessment of LV GLS with 2D speckle-tracking echocardiography has been shown to be an accurate marker of LV function. 22, 25 Stanton et al 13 reported in a retrospective analysis of 546 unselected patients that LV GLS assessed with 2D speckletracking echocardiography had incremental value over LVEF and WMSI for the prediction of outcome. Furthermore, the authors showed that LV GLS assessment was more reproducible as compared with LVEF assessment. 13 These findings were also confirmed in subsequent series of heart failure patients. 14, 26 Thus far, the largest series reporting the prognostic value of GLS included 603 patients with acute myocardial infarction, 27 697 patients with ST-segment elevation-acute myocardial infarction treated with primary coronary intervention, 11 and 546 unselected patients clinically referred for echocardiography (34% had prior myocardial infarction and 17% had prior coronary revascularization). 13 The present patient population is unique because it includes a homogeneous population with chronic ischemic heart disease and is far larger (nϭ1060) compared with previous series. Furthermore, the current study provides further insight into the prognostic value of LV GLS in patients with chronic ischemic heart disease. In this group of patients, assessment of LV systolic function may be challenged by the presence of wall motion abnormalities 
GLS and Long-Term Outcome
The prognosis of patients with coronary artery disease is influenced by several clinical parameters. 2, 17 Similarly to previous series, the present study showed that age, diabetes, hemoglobin levels, and renal function (assessed as GFR) were significantly and independently related to all-cause mortality in patients with chronic ischemic cardiomyopathy. 2, 17 More importantly, the present study demonstrated the superior prognostic value of LV GLS over these clinical well-established predictors of mortality. Furthermore, LV GLS provided significant incremental value over the clinical independent predictors of long-term outcome. Particularly, in the present evaluation, the patient population was dichotomized on the basis of the median value of LV GLS (Ϫ11.5%), showing a significantly better long-term survival for patients with less impaired LV GLS. This finding underscores that LV GLS assessed with 2D speckle-tracking echocardiography may be used as a novel index of LV longitudinal function and also as a strong predictor of all-cause mortality in patients with chronic ischemic cardiomyopathy. 22, 25 
Study Limitations
Although the present evaluation was retrospective in design, this is the largest population cohort in which LV GLS was analyzed. An additional limitation to the present study is that radial and circumferential strains were not explored. However, it has recently been proven that longitudinal deformation may be a more sensitive marker of cardiac function compared with radial or circumferential strain. 28, 29 This issue is particularly relevant in chronic ischemic patients. 29 Other echocardiographic parameters related to long-term outcome of patients with chronic ischemic heart disease such as left atrial volume, mitral regurgitation, and diastolic function were not evaluated.
Conclusion
LV GLS with speckle-tracking echocardiography is significantly related to long-term outcome in patients with chronic ischemic cardiomyopathy.
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